Literature DB >> 18412710

Infection control measures to limit the spread of Clostridium difficile.

R-P Vonberg1, E J Kuijper, M H Wilcox, F Barbut, P Tüll, P Gastmeier, P J van den Broek, A Colville, B Coignard, T Daha, S Debast, B I Duerden, S van den Hof, T van der Kooi, H J H Maarleveld, E Nagy, D W Notermans, J O'Driscoll, B Patel, S Stone, C Wiuff.   

Abstract

Clostridium difficile-associated diarrhoea (CDAD) presents mainly as a nosocomial infection, usually after antimicrobial therapy. Many outbreaks have been attributed to C. difficile, some due to a new hyper-virulent strain that may cause more severe disease and a worse patient outcome. As a result of CDAD, large numbers of C. difficile spores may be excreted by affected patients. Spores then survive for months in the environment; they cannot be destroyed by standard alcohol-based hand disinfection, and persist despite usual environmental cleaning agents. All these factors increase the risk of C. difficile transmission. Once CDAD is diagnosed in a patient, immediate implementation of appropriate infection control measures is mandatory in order to prevent further spread within the hospital. The quality and quantity of antibiotic prescribing should be reviewed to minimise the selective pressure for CDAD. This article provides a review of the literature that can be used for evidence-based guidelines to limit the spread of C. difficile. These include early diagnosis of CDAD, surveillance of CDAD cases, education of staff, appropriate use of isolation precautions, hand hygiene, protective clothing, environmental cleaning and cleaning of medical equipment, good antibiotic stewardship, and specific measures during outbreaks. Existing local protocols and practices for the control of C. difficile should be carefully reviewed and modified if necessary.

Entities:  

Mesh:

Year:  2008        PMID: 18412710     DOI: 10.1111/j.1469-0691.2008.01992.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  73 in total

1.  Understanding the current state of infection prevention to prevent Clostridium difficile infection: a human factors and systems engineering approach.

Authors:  Eric Yanke; Caroline Zellmer; Sarah Van Hoof; Helene Moriarty; Pascale Carayon; Nasia Safdar
Journal:  Am J Infect Control       Date:  2015-03-01       Impact factor: 2.918

2.  Identification of a genetic locus responsible for antimicrobial peptide resistance in Clostridium difficile.

Authors:  Shonna M McBride; Abraham L Sonenshein
Journal:  Infect Immun       Date:  2010-10-25       Impact factor: 3.441

3.  Quasiexperimental study of the effects of antibiotic use, gastric acid-suppressive agents, and infection control practices on the incidence of Clostridium difficile-associated diarrhea in hospitalized patients.

Authors:  Mamoon A Aldeyab; Stephan Harbarth; Nathalie Vernaz; Mary P Kearney; Michael G Scott; Chris Funston; Karen Savage; Denise Kelly; Motasem A Aldiab; James C McElnay
Journal:  Antimicrob Agents Chemother       Date:  2009-03-16       Impact factor: 5.191

4.  An outbreak of Clostridium difficile-associated disease (CDAD) in a German university hospital.

Authors:  K Graf; A Cohrs; P Gastmeier; A Kola; R-P Vonberg; F Mattner; D Sohr; I F Chaberny
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-11-04       Impact factor: 3.267

5.  Control of Clostridium difficile-associated diarrhea by antibiotic stewardship in a small community hospital.

Authors:  Alice Schabas; David N Fisman; Richard Schabas
Journal:  Can J Infect Dis Med Microbiol       Date:  2012       Impact factor: 2.471

Review 6.  Probiotics for prevention of Clostridium difficile infection.

Authors:  John P Mills; Krishna Rao; Vincent B Young
Journal:  Curr Opin Gastroenterol       Date:  2018-01       Impact factor: 3.287

7.  Antibiotic treatment of clostridium difficile carrier mice triggers a supershedder state, spore-mediated transmission, and severe disease in immunocompromised hosts.

Authors:  Trevor D Lawley; Simon Clare; Alan W Walker; David Goulding; Richard A Stabler; Nicholas Croucher; Piero Mastroeni; Paul Scott; Claire Raisen; Lynda Mottram; Neil F Fairweather; Brendan W Wren; Julian Parkhill; Gordon Dougan
Journal:  Infect Immun       Date:  2009-06-29       Impact factor: 3.441

8.  The evolution of drug resistance and the curious orthodoxy of aggressive chemotherapy.

Authors:  Andrew F Read; Troy Day; Silvie Huijben
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-20       Impact factor: 11.205

9.  Functional characterization of Clostridium difficile spore coat proteins.

Authors:  Patima Permpoonpattana; Jutarop Phetcharaburanin; Anna Mikelsone; Marcin Dembek; Sisareuth Tan; Marie-Clémence Brisson; Roberto La Ragione; Alain R Brisson; Neil Fairweather; Huynh A Hong; Simon M Cutting
Journal:  J Bacteriol       Date:  2013-01-18       Impact factor: 3.490

10.  A novel subtyping assay for detection of Clostridium difficile virulence genes.

Authors:  Stephanie L Angione; Aartik A Sarma; Aleksey Novikov; Leah Seward; Jennifer H Fieber; Leonard A Mermel; Anubhav Tripathi
Journal:  J Mol Diagn       Date:  2014-01-13       Impact factor: 5.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.